Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aulois-Griot

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Annales Pharmaceutiques Francaises|March 6, 2021
[Clinical medication review in French community pharmacy: Interest of a new pharmaceutical service for detection of drug related problems]D Bonnan, F Amouroux, M Aulois-Griot
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Orphan Drug Pricing In France: Influence of Main FactorsH Grand, A L Samson, M Aulois-Griot
Revue D'Epidemiologie Et De Sante Publique|September 3, 2013
[Exception drugs status: specific characteristics and the role in the proper use of drugs]I Gridchyna, M Baumevieille, M Aulois-Griot, et al.
Medecine Et Maladies Infectieuses|April 8, 2019
Antibiotic misuse: How to evaluate the costs?M L Silva, C Cargnello, M Aulois-Griot, et al.
Annales De Biologie Clinique|October 1, 1998
[Recommendations concerning point-of-care systems. "Point-of-care systems" work group of the French Society of Clinical Biology and National College of Hospital Biochemistry]J Goudable, M Aulois-Griot, P Billion, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Annales Pharmaceutiques Francaises|March 6, 2021
[Clinical medication review in French community pharmacy: Interest of a new pharmaceutical service for detection of drug related problems]D Bonnan, F Amouroux, M Aulois-Griot
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Orphan Drug Pricing In France: Influence of Main FactorsH Grand, A L Samson, M Aulois-Griot
Revue D'Epidemiologie Et De Sante Publique|September 3, 2013
[Exception drugs status: specific characteristics and the role in the proper use of drugs]I Gridchyna, M Baumevieille, M Aulois-Griot, et al.
Medecine Et Maladies Infectieuses|April 8, 2019
Antibiotic misuse: How to evaluate the costs?M L Silva, C Cargnello, M Aulois-Griot, et al.
Annales De Biologie Clinique|October 1, 1998
[Recommendations concerning point-of-care systems. "Point-of-care systems" work group of the French Society of Clinical Biology and National College of Hospital Biochemistry]J Goudable, M Aulois-Griot, P Billion, et al.
Pageof 1